Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2005 Apr;15(4):829-32.
doi: 10.1007/s00330-004-2484-0. Epub 2004 Sep 22.

Application of an exogenous hyperoxic contrast agent in MR mammography: initial results

Affiliations
Case Reports

Application of an exogenous hyperoxic contrast agent in MR mammography: initial results

Dorothee R Fischer et al. Eur Radiol. 2005 Apr.

Abstract

There is interest in applying novel methods to dynamic MR mammography (MRM). One such possibility is to administer an exogenous hyperoxic contrast agent, such as carbogen (95-98% O2 and 2-5% CO2) or pure oxygen (100% O2). We report our first experiences with these agents in a patient with an invasive lobular carcinoma. Fourteen dynamic series were acquired with an rf-spoiled 2D multislice gradient echo sequence, including three measurements while breathing air, four measurements with 100% oxygen, three measurements with air and four measurements with carbogen. Afterwards, 0.1 mmol/kg bw of Gd-DTPA was administered to obtain dynamic T1-weighted double-echo 3D axial gradient echo images (TR/TE1/TE2/alpha=7.8 ms/2 ms/4.76 ms/15 degrees) every 90 s up to 4.5 min after injection. The lesion was well delineated on the contrast-enhanced images, contrary to magnitude images reconstructed from the raw data sets acquired during air/oxygen/carbogen breathing. A ROI-based median-filtered signal-time course revealed a tumor signal increase of roughly 15% between scans acquired during air and oxygen breathing. Though preliminary, these first results are encouraging concerning the exploration of these alternative contrast agents in MRM in greater detail.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur Radiol. 2004 Aug;14(8):1363-70 - PubMed
    1. Eur Radiol. 2004 Mar;14 (3):394-401 - PubMed
    1. Eur J Radiol. 1997 Feb;24(2):94-108 - PubMed
    1. Magn Reson Imaging. 2001 Feb;19(2):161-6 - PubMed
    1. Magn Reson Med. 1995 Mar;33(3):318-25 - PubMed

Publication types

LinkOut - more resources